UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$288M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$215M |
| 3 |
Tractor Supply
TSCO
|
+$157M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
PayPal
PYPL
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$339M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$244M |
| 3 |
PX
Praxair Inc
PX
|
+$218M |
| 4 |
Meta Platforms (Facebook)
META
|
+$182M |
| 5 |
Adobe
ADBE
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 14.9% |
| 3 | Financials | 14.08% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TELL
1926
DELISTED
Tellurian Inc.
TELL
| $536K | ﹤0.01% |
77,077
+4,911
| +7% | +$38K |
|
1927
Lattice Semiconductor
LSCC
$18.5B
| $534K | ﹤0.01% |
77,118
+5,667
| +8% | +$38.2K |
|
|
IMGN
1928
DELISTED
Immunogen Inc
IMGN
| $533K | ﹤0.01% |
111,031
+16,821
| +18% | +$102K |
|
|
XOG
1929
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $532K | ﹤0.01% |
124,120
+14,260
| +13% | +$106K |
|
1930
Gibraltar Industries
ROCK
$1.49B
| $532K | ﹤0.01% |
14,939
+71
| +0.5% | +$2.59K |
|
|
ACH
1931
Accendra Health
ACH
$214M
| $531K | ﹤0.01% |
83,844
+1,507
| +2% | +$15.6K |
|
1932
ORIX
IX
$43.5B
| $530K | ﹤0.01% |
37,005
-145
| -0.4% | -$2.27K |
|
1933
US Physical Therapy
USPH
$1.22B
| $529K | ﹤0.01% |
5,171
+12
| +0.2% | +$1.33K |
|
1934
Precigen
PGEN
$2.59B
| $529K | ﹤0.01% |
80,852
+48,675
| +151% | +$545K |
|
|
ANAT
1935
DELISTED
American National Group, Inc. Common Stock
ANAT
| $527K | ﹤0.01% |
4,141
-1,569
| -27% | -$195K |
|
|
RDFN
1936
DELISTED
Redfin
RDFN
| $525K | ﹤0.01% |
36,492
+4,879
| +15% | +$77.5K |
|
|
LNW
1937
DELISTED
Light & Wonder
LNW
| $525K | ﹤0.01% |
29,366
-8,829
| -23% | -$178K |
|
1938
Skywest
SKYW
$4.34B
| $524K | ﹤0.01% |
11,792
-2,985
| -20% | -$154K |
|
1939
Oil States International
OIS
$491M
| $524K | ﹤0.01% |
36,668
-7,198
| -16% | -$166K |
|
1940
FormFactor
FORM
$9.17B
| $522K | ﹤0.01% |
37,060
+2,404
| +7% | +$33.5K |
|
1941
Theravance Biopharma
TBPH
$877M
| $521K | ﹤0.01% |
20,377
+3,100
| +18% | +$83.7K |
|
1942
CVR Energy
CVI
$3.13B
| $521K | ﹤0.01% |
15,118
| – | – |
|
1943
Insmed
INSM
$28.6B
| $521K | ﹤0.01% |
39,720
-10,103
| -20% | -$161K |
|
1944
Heritage Financial
HFWA
$1.21B
| $521K | ﹤0.01% |
17,524
| – | – |
|
|
MODV
1945
DELISTED
ModivCare
MODV
| $521K | ﹤0.01% |
8,675
| – | – |
|
|
HAPN
1946
Happen Inc
HAPN
$2.24B
| $519K | ﹤0.01% |
39,467
+2,280
| +6% | +$37.6K |
|
1947
Stoneridge
SRI
$213M
| $519K | ﹤0.01% |
21,038
+8,338
| +66% | +$212K |
|
1948
Federal Signal
FSS
$7.83B
| $518K | ﹤0.01% |
26,036
-3,344
| -11% | -$76.2K |
|
1949
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $517K | ﹤0.01% |
20,775
| – | – |
|
|
INOV
1950
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $515K | ﹤0.01% |
36,317
+25,017
| +221% | +$285K |
|
Similar funds
UBS AM's Q4 2018 Portfolio in Review
As of Q4 2018, UBS AM held 2,899 positions worth $116B, down 14% from $135B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS AM's Q4 2018 filing shows 140 new, 1,359 increased, 845 reduced and 130 closed positions. Its largest new stake was Linde: 1,823,057 shares worth $284M. The largest sale was Aetna Inc, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2018 buy was Linde: 1,823,057 shares worth $284M.
- UBS AM added most to iShares US Treasury Bond ETF in Q4 2018, an estimated $215M increase.
- UBS AM's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $182M.
- UBS AM fully exited Aetna Inc in Q4 2018, selling an estimated $339M.
- UBS AM's ten largest holdings make up 17% of its $116B portfolio in Q4 2018.
- UBS AM opened 140 new positions and closed 130 in Q4 2018.
- UBS AM's portfolio value fell 14% quarter-over-quarter to $116B.
Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.